Charles River Laboratories International, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Charles River Laboratories reports a decrease in revenue and operating income for fiscal year 2024, impacted by industry-wide challenges and restructuring activities.
NYSE
Charles River Laboratories' 2023 annual report reveals a year of revenue growth tempered by economic caution and strategic adjustments.